Calibration of the IQVIA Core Diabetes Model to the stroke outcomes from the SUSTAIN 6 cardiovascular outcomes trial of once-weekly semaglutide.
Saved in:
| Title: | Calibration of the IQVIA Core Diabetes Model to the stroke outcomes from the SUSTAIN 6 cardiovascular outcomes trial of once-weekly semaglutide. |
|---|---|
| Authors: | Berry S; Novo Nordisk Ltd, Gatwick, UK., Chubb B; Novo Nordisk A/S, Søborg, Denmark., Acs A; Novo Nordisk A/S, Søborg, Denmark., Falla E; IQVIA Ltd., Real World Solutions, London, UK., Verma A; IQVIA Ltd., Real World Solutions, London, UK., Malkin SJP; Ossian Health Economics and Communications, Basel, Switzerland., Hunt B; Ossian Health Economics and Communications, Basel, Switzerland., Palmer AJ; Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia. |
| Source: | Journal of medical economics [J Med Econ] 2023 Jan-Dec; Vol. 26 (1), pp. 1019-1031. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: England NLM ID: 9892255 Publication Model: Print Cited Medium: Internet ISSN: 1941-837X (Electronic) Linking ISSN: 13696998 NLM ISO Abbreviation: J Med Econ Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1941-837X |
|---|---|
| DOI: | 10.1080/13696998.2023.2240957 |
